Pharmacotherapy for the Treatment of Cannabis Use Disorder: A Systematic Review

Review of 26 studies concludes based on low- to moderate-strength evidence, buspirone, cannabinoids, and SSRIs are ineffective for decreasing cannabis use or improving abstinence. Evidence is limited because of small sample sizes and other methodological flaws.


Annals of Internal Medicine